Home

Onderzoek leerling satelliet rivaroxaban atrial fibrillation dose Empirisch meester boog

Table 1 from Choosing a particular oral anticoagulant and dose for stroke  prevention in individual patients with non-valvular atrial fibrillation:  part 2. | Semantic Scholar
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar

Clinical Risk Factors of Thromboembolic and Major Bleeding Events for  Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan -  Journal of Stroke and Cerebrovascular Diseases
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases

Xarelto® – Dosing – Stroke Prevention in Atrial Fibrillation
Xarelto® – Dosing – Stroke Prevention in Atrial Fibrillation

Dosing of direct oral anticoagulants in atrial fibrillation based on... |  Download Table
Dosing of direct oral anticoagulants in atrial fibrillation based on... | Download Table

Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in  Patients with Non-Valvular Atrial Fibrillation: A Nationwide,  Population-Based Cohort Study | Scientific Reports
Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study | Scientific Reports

Rivaroxaban: a fully-subsidised oral anticoagulant
Rivaroxaban: a fully-subsidised oral anticoagulant

Xarelto® - Dosing Guide
Xarelto® - Dosing Guide

Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events | AAFP
Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events | AAFP

Dosing of direct oral anticoagulants in atrial fibrillation based on... |  Download Table
Dosing of direct oral anticoagulants in atrial fibrillation based on... | Download Table

ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment |  ELIQUIS UK
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK

Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended  Doses of Direct Oral Anticoagulants - ScienceDirect
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants - ScienceDirect

The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? -  American College of Cardiology
The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology

Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians  With Atrial Fibrillation - ScienceDirect
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect

Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and  Normal or Mildly Impaired Renal Function | Semantic Scholar
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Semantic Scholar

Xa Inhibitors - Apixaban and Rivaroxaban Oral Xa ... | GrepMed
Xa Inhibitors - Apixaban and Rivaroxaban Oral Xa ... | GrepMed

Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve | NEJM
Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve | NEJM

Real-world safety and effectiveness of rivaroxaban using Japan-specific  dosage during long-term follow-up in patients with atrial fibrillation:  XAPASS | PLOS ONE
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE

Xarelto® - Dosing Guide
Xarelto® - Dosing Guide

Remedial dosing recommendation for delayed or missed rivaroxaban doses for  patients with non-valvular atrial fibrillation based on Monte Carlo  simulation | medRxiv
Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv

Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and  Normal or Mildly Impaired Renal Function | Stroke
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function | Stroke

Target-Specific Oral Anticoagulants
Target-Specific Oral Anticoagulants

Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke  Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting  in India: A Literature Review | Article
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article

Xarelto® - Dosing Guide
Xarelto® - Dosing Guide

Xarelto®(rivaroxaban) Prescriber Guide
Xarelto®(rivaroxaban) Prescriber Guide

Direct Oral Anticoagulants - ppt video online download
Direct Oral Anticoagulants - ppt video online download

What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial  Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon,  Hyung Wook Park, Jeong Gwan Cho,
What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg? - Sung Soo Kim, Ki Hong Lee, Nam Sik Yoon, Hyung Wook Park, Jeong Gwan Cho,